This week, ECG247 is participating in the World Stroke Congress – the world’s leading meeting place for healthcare professionals working in stroke prevention, treatment, and rehabilitation. With attendees from over 100 countries, the conference is a key arena for innovation – and ECG247 is proud to be represented.

Atrial fibrillation (AF) is one of the most important risk factors for stroke and is often only detected after a stroke has occurred. That’s why screening for heart rhythm disturbances after a stroke is crucial to prevent future incidents. ECG247 offers a unique solution that makes this possible – simple, effective, and accessible.

“ECG247 enables neurologists and stroke teams to conduct atrial fibrillation screening without needing to refer patients to a cardiologist,” says Siri Lindland, Sales Manager at ECG247.

Our wireless sensor allows for continuous heart rhythm monitoring over several days. This enables faster diagnostics and better patient flow – especially important in post-stroke follow-up.

ECG247 is already in use at several Norwegian hospitals and in major research projects. At the World Stroke Congress, ECG247 is engaging with a global professional community that shares the ambition to improve stroke care through technology and early intervention.

“We’re seeing strong international interest in our solution, and it’s inspiring to be part of the global conversation about the future of stroke treatment,” says Lindland.

With ECG247 as a tool, healthcare professionals can detect hidden atrial fibrillation earlier – and thereby help reduce the risk of recurrent strokes.